Drug Sponsors

EMD Serono to open $115M life science campus in Massachusetts

Tuesday, July 19, 2016

EMD Serono, known as Merck outside of the U.S. and Canada, a science and technology company, has announced plans to build a new campus in Burlington, Massachusetts, that will serve as a major hub for the North American life science business of Merck. The 280,000-square-foot facility will include a customer collaboration laboratory and training center as well as office space.

[Read More]

Bristol-Myers Squibb acquires Cormorant Pharmaceuticals

Tuesday, July 5, 2016

Bristol-Myers Squibb has acquired all of the outstanding capital stock of Cormorant Pharmaceuticals, a private, Stockholm, Sweden-based pharmaceutical company focused on the development of therapies for cancer and rare diseases. The acquisition gives Bristol-Myers Squibb full rights to Cormorant’s HuMax-IL8 antibody program and the lead candidate HuMax-IL8, a phase I/II monoclonal antibody targeted against interleukin-8 (IL-8) that represents a potentially complementary immuno-oncology mechanism of action to T-cell directed antibodies and co-stimulatory molecules.

[Read More]

Biogen selects Cognizant’s SmartTrials Platform

Friday, July 1, 2016

Biogen has selected Cognizant‘s SmartTrials platform to aggregate and store clinical trial operational and patient data. Cambridge, Mass.-based Biogen has a portfolio of medicines to treat multiple sclerosis (MS) and is at the forefront of neurology research, working to develop novel therapies for conditions with few or no treatment options.

[Read More]

Richter acquires Finox Holding for $185.2M

Friday, July 1, 2016

Gedeon Richter has announced the acquisition of Finox Holding, a privately held Swiss biotech company focused on development and commercialization of innovative and cost effective products addressing female fertility. Gedeon Richter, headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. 

[Read More]